To further confirm the role of DEK expression in HCC progression, we analyzed the 5-years survival rate of 178 HCC cases by Kaplan-meier, and found that HCC patients with DEK expression had a lower 5-years survival rate than those without DEK expression, P<0.001 (Fig. 2A). This evidence concerns the gene DEK and hepatocellular carcinoma.